Elevated prolactin is not known to affect development of any tumor types aside from a modest association with breast cancer and there is no biological knowledge supporting a connection to the incidence of any kinds of lung tumors (Tikk et al. 2015). This evidence concerns the gene PRL and breast carcinoma.